Skip to main content
SpringerLink
Log in

Antineoplastics

Various toxicities: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Birendra KC, et al. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120. Clinical Lymphoma, Myeloma & Leukemia 16: 460-465, No. 8, Aug 2016. Available from: URL: http://doi.org/10.1016/j.clml.2016.04.006 - USA

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1677, 38 (2017). https://doi.org/10.1007/s40278-017-38316-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-38316-7

Search

Navigation